Impaired wound healing secondary to bevacizumab

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/150555/1/iwj13139_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/150555/2/iwj13139.pd

Properties and characterization of biodiesel from selected microalgea stains

The demand for alternative fuels has increased in the past several years[1]. Biofuels are gaining importance as significant substitutes for the depleting fossil fuels. The fact that biofuels are renewable fuels with very low emissions of CO2 in the lifecycle offers them a competitive advantage[2]. However, the first produced biodiesel derived from edible oil seed crops (first generation feedstocks), lurking a serious risk of disturbing the overall worldwide balance of food reserves and safety. The second generation feedstocks for biodiesel production obtained from non-edible oil seed crops, waste cooking oil, animal fats, etc., but these feedstocks are not sufficient to cover the present energy needs. Recent focus is on microalgae as the third generation feedstock[3]. Mi l d t t f l d b t th i lt ( ) b kih(l ) df h Microalgae do not compete for land, but they can grow in salty sea), brackish (lagoons) and fresh (lakes) water. Moreover, microalgae have high photosynthetic efficiency using solar energy, water and carbon dioxide to produce higher quantities of biomass than other feedstocks. In the present research work, two indigenous fresh water (ChlorF1, ChlorF2) and two marine (ChlorM1, ChlorM2) Chlorophyte strains have been cultivated successfully under laboratory conditions using commercial fertilizer (Nutrileaf 30-10-10, initial concentration=70 g/m3) as nutrient source. The produced biodiesel from the microalgae biomass achieved a range of 2.2 - 10.6% total lipid content and an unsaturated FAME content between 48 mol% and 59 mol%. The iodine value, the cetane number, the cold filter plugging point (CFPP) and the oxidative stability of the ultimate biodiesels were determined, based on the compositions of the four (4) microalgae strains and compared with the specifications in the EU and US standards, EN 14214 and ASTM D6751 respectively

The unresolved case of sacral chordoma: from misdiagnosis to challenging surgery and medical therapy resistance.

PURPOSE: A sacral chordoma is a rare, slow-growing, primary bone tumor, arising from embryonic notochordal remnants. Radical surgery is the only hope for cure. The aim of our present study is to analyse our experience with the challenging treatment of this rare tumor, to review current treatment modalities and to assess the outcome based on R status. METHODS: Eight patients were treated in our institution between 2001 and 2011. All patients were discussed by a multidisciplinary tumor board, and an en bloc surgical resection by posterior perineal access only or by combined anterior/posterior accesses was planned based on tumor extension. RESULTS: Seven patients underwent radical surgery, and one was treated by using local cryotherapy alone due to low performance status. Three misdiagnosed patients had primary surgery at another hospital with R1 margins. Reresection margins in our institution were R1 in two and R0 in one, and all three recurred. Four patients were primarily operated on at our institution and had en bloc surgery with R0 resection margins. One had local recurrence after 18 months. The overall morbidity rate was 86% (6/7 patients) and was mostly related to the perineal wound. Overall, 3 out of 7 resected patients were disease-free at a median follow-up of 2.9 years (range, 1.6-8.0 years). CONCLUSION: Our experience confirms the importance of early correct diagnosis and of an R0 resection for a sacral chordoma invading pelvic structures. It is a rare disease that requires a challenging multidisciplinary treatment, which should ideally be performed in a tertiary referral center

A DYNAMIC CONTENT MANAGEMENT SYSTEM FOR THE VISUALIZATION OF CULTURAL INFORMATION; THE CASE OF THE STATE CONSERVATORY OF THESSALONIKI, GR

Although there are several attempts of embedding static content in events’ brochures and posters, the increasing need for flexibility and versatility of the content, leads to the development of a mobile application with an in-app dynamic content management system. In this context, DigiOrch is an ongoing research program where, a Content Management System is developed to organize all the digital material and maintain the appropriate connection to the analogical markers. Furthermore, a mobile application is developed that lev-erages this system using in app dynamic modules, which, by utilizing the augmented reality technology, presents multimedia data such as texts, photos, videos, and 3D Models to the end-user by “superimposing” them on mobile devices screen, providing extra additional information on any valid smart-leaflet.The overall workflow of the in-app Dynamic Content Management System (DCMS) can be described as a group of modules that managing and copying content files from a remote infrastructure such as an ftp server or a local resource if network is missing, to the mobile device’s file system.The in-app DCMS consists of 4 modules: The first module is the parser, which is responsible for reading a downloaded *.json file and creating content-linked objects. The second module is the download module which is responsible for downloading the overall content by iterating the content-linked objects, created by the previous module. The third module le is the update module that, by iterating the initial content file and the local file system, suggests whether a content update is necessary. The fourth module is the loading module, which is responsible for fetching the content on runtime to fill the content-holding components, such as 3D Models and UI photo galleries, of the AR scenes on runtime.</p

VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation via macropinocytosis

Endocytosis plays critical role in receptor signalling. VEGFR2 and its ligand VEGFA are fundamental in neovascularization. Yet, our understanding of the role of endocytosis in VEGFR2 signalling remains limited. Despite the existence of diverse internalisation routes, the only known endocytic pathway of VEGFR2 is the clathrin-mediated. Here, we show that this pathway is the predominant internalisation route of VEGFR2 only in the absence of ligand. Intriguingly, VEGF introduces a novel internalisation itinerary for VEGFR2, the pathway of macropinocytosis, which becomes the prevalent endocytic route of the receptor in the presence of ligand, while the route of clathrin becomes minor. Macropinocytic internalisation of VEGFR2, which mechanistically is mediated via the small GTPase CDC42, takes place via macropinosomes generated at ruffling areas of the membrane. Interestingly, macropinocytosis plays critical role in VEGF-induced signalling, endothelial cell functions in vitro and angiogenesis in vivo, while clathrin-mediated endocytosis is not essential for VEGF signalling. These findings expand our knowledge on the endocytic pathways of VEGFR2 and suggest that VEGF-driven internalisation of VEGFR2 via macropinocytosis is essential for endothelial cell signalling and angiogenesis

Delayed presentation of an isolated gallbladder rupture following blunt abdominal trauma: a case report

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Pamidronic acid and cabergoline as effective long-term therapy in a 12-year-old girl with extended facial polyostotic fibrous dysplasia, prolactinoma and acromegaly in McCune-Albright syndrome: a case report

<p>Abstract</p> <p>Introduction</p> <p>McCune-Albright syndrome is a complex inborn disorder due to early embryonal postzygotic somatic activating mutations in the <it>GNAS</it>1 gene. The phenotype is very heterogeneous and includes polyostotic fibrous dysplasia, typically involving the facial skull, numerous café-au-lait spots and autonomous hyperfunctions of several endocrine systems, leading to hyperthyroidism, hypercortisolism, precocious puberty and acromegaly.</p> <p>Case presentation</p> <p>Here, we describe a 12-year-old Caucasian girl with severe facial involvement of fibrous dysplasia, along with massive acromegaly due to growth hormone excess and precocious puberty, with a prolactinoma. Our patient was treated with a bisphosphonate and the prolactin antagonist, cabergoline, resulting in the inhibition of fibrous dysplasia and involution of both the prolactinoma and growth hormone excess. During a follow-up of more than two years, no severe side effects were noted.</p> <p>Conclusion</p> <p>Treatment with bisphosphonates in combination with cabergoline is a suitable option in patients with McCune-Albright syndrome, especially in order to circumvent surgical interventions in patients suffering from polyostotic fibrous dysplasia involving the skull base.</p

Adjustment of Insulin Pump Settings in Type 1 Diabetes Management: Advisor Pro Device Compared to Physicians’ Recommendations

Aims: To compare insulin dose adjustments made by physicians to those made by an artificial intelligence-based decision support system, the Advisor Pro, in people with type 1 diabetes (T1D) using an insulin pump and self-monitoring blood glucose (SMBG). Methods: This was a multinational, non-interventional study surveying 17 physicians from 11 countries. Each physician was asked to provide insulin dose adjustments for the settings of the pump including basal rate, carbohydrate-to-insulin ratios (CRs), and correction factors (CFs) for 15 data sets of pumps and SMBG of people with T1D (mean age 18.4 ± 4.8 years; eight females; mean glycated hemoglobin 8.2% ± 1.4% [66 ± 11mmol/mol]). The recommendations were compared among the physicians and between the physicians and the Advisor Pro. The study endpoint was the percentage of comparison points for which there was an agreement on the direction of insulin dose adjustments. Results: The percentage (mean ± SD) of agreement among the physicians on the direction of insulin pump dose adjustments was 51.8% ± 9.2%, 54.2% ± 6.4%, and 49.8% ± 11.6% for the basal, CR, and CF, respectively. The automated recommendations of the Advisor Pro on the direction of insulin dose adjustments were comparable)49.5% ± 6.4%, 55.3% ± 8.7%, and 47.6% ± 14.4% for the basal rate, CR, and CF, respectively(and noninferior to those provided by physicians. The mean absolute difference in magnitude of change between physicians was 17.1% ± 13.1%, 14.6% ± 8.4%, and 23.9% ± 18.6% for the basal, CR, and CF, respectively, and comparable to the Advisor Pro 11.7% ± 9.7%, 10.1% ± 4.5%, and 25.5% ± 19.5%, respectively, significant for basal and CR. Conclusions: Considerable differences in the recommendations for changes in insulin dosing were observed among physicians. Since automated recommendations by the Advisor Pro were similar to those given by physicians, it could be considered a useful tool to manage T1D

Asymmetry of Early Endosome Distribution in C. elegans Embryos

development, we examined the distribution and dynamics of early endosomes (EEs) in embryos.EEs are primarily found at the cell periphery with an initially uniform distribution after fertilization. Strikingly, we find that during the first cell cycle, EEA-1 positive EEs become enriched at the anterior cortex. In contrast, the Golgi compartment shows no asymmetry in distribution. Asymmetric enrichment of EEs depends on acto-myosin contractility and embryonic PAR polarity. In addition to their localization at the cortex, EEs are also found around the centrosome. These EEs move rapidly (1.3um/s) from the cortex directly to the centrosome, a speed comparable to that of the minus end directed motor dynein.We speculate that the asymmetry of early endosomes might play a role in cell asymmetries or fate decisions

Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge

Background: Several studies have evaluated predictors for complications of endoscopic retrograde cholangiopancreatography (ERCP), but their relative importance is unknown. In addition, currently used blood tests to detect post-ERCP pancreatitis are inconsistent. The aim of this study was to determine predictors of post-ERCP complications that could discriminate between patients at highest and lowest risk of post-ERCP complications and to develop a model that is able to identify patients that can safely be discharged shortly after ERCP. Methods: In a single-center, retrospective analysis over the period 2002-2007, predictors of post-ERCP complications were evaluated in a multivariable analysis and compared with those identified from a literature review. A prognostic model was developed based on these risk factors, which was further evaluated in a prospective patient population. Results: From our retrospective analysis and literature review, we selected the eight most important risk factors for post-ERCP pancreatitis and cholangitis. In the prognostic model, the risk factors (precut) sphincterotomy, sphincter of Oddi dysfunction, younger age, female gender, history of pancreatitis, p